These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lack of tumour pigmentation in conjunctival melanoma is associated with light iris colour and worse prognosis. Brouwer NJ; Marinkovic M; Luyten GPM; Shields CL; Jager MJ Br J Ophthalmol; 2019 Mar; 103(3):332-337. PubMed ID: 29777046 [TBL] [Abstract][Full Text] [Related]
3. [Melanoma of the conjunctiva and its treatment]. Zografos L; Uffer S; Gailloud C; Bercher L Klin Monbl Augenheilkd; 1990 May; 196(5):285-9. PubMed ID: 2366455 [TBL] [Abstract][Full Text] [Related]
4. Pigmented lesions of the conjunctiva. Farber M; Schutzer P; Mihm MC J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):971-8. PubMed ID: 9632007 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of a red chromagen in the diagnosis of melanocytic lesions of the conjunctiva. Jiang K; Brownstein S; Lam K; Burns B; Farmer J JAMA Ophthalmol; 2014 May; 132(5):622-9. PubMed ID: 24626521 [TBL] [Abstract][Full Text] [Related]
6. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Shields CL; Shields JA; Gündüz K; Cater J; Mercado GV; Gross N; Lally B Arch Ophthalmol; 2000 Nov; 118(11):1497-507. PubMed ID: 11074806 [TBL] [Abstract][Full Text] [Related]
7. [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up]. Lommatzsch PK; Werschnik C Klin Monbl Augenheilkd; 2002 Oct; 219(10):710-21. PubMed ID: 12447715 [TBL] [Abstract][Full Text] [Related]
8. A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations. Larsen AC; Dahmcke CM; Dahl C; Siersma VD; Toft PB; Coupland SE; Prause JU; Guldberg P; Heegaard S JAMA Ophthalmol; 2015 Nov; 133(11):1295-303. PubMed ID: 26425792 [TBL] [Abstract][Full Text] [Related]
9. Satellite in transit metastases in rapidly fatal conjunctival melanoma: implications for angiotropism and extravascular migratory metastasis (description of a murine model for conjunctival melanoma). Barnhill RL; Lemaitre S; Lévy-Gabrielle C; Rodrigues M; Desjardins L; Dendale R; Vincent-Salomon A; Roman-Roman S; Lugassy C; Cassoux N Pathology; 2016 Feb; 48(2):166-76. PubMed ID: 27020389 [TBL] [Abstract][Full Text] [Related]
10. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile. Larsen AC Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168 [TBL] [Abstract][Full Text] [Related]
11. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Shields CL Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037 [TBL] [Abstract][Full Text] [Related]
12. Treatment of conjunctival melanoma in a Dutch referral centre. Brouwer NJ; Marinkovic M; van Duinen SG; Bleeker JC; Jager MJ; Luyten GPM Br J Ophthalmol; 2018 Sep; 102(9):1277-1282. PubMed ID: 29122819 [TBL] [Abstract][Full Text] [Related]
13. Ophthalmologic oncology: conjunctival malignant melanoma in association with sporadic dysplastic nevus syndrome. Friedman RJ; Rodríguez-Sains R; Jakobiec F J Dermatol Surg Oncol; 1987 Jan; 13(1):31-4. PubMed ID: 3794047 [No Abstract] [Full Text] [Related]
14. Advances in the management of conjunctival melanoma. Vora GK; Demirci H; Marr B; Mruthyunjaya P Surv Ophthalmol; 2017; 62(1):26-42. PubMed ID: 27321895 [TBL] [Abstract][Full Text] [Related]
15. Conjunctival melanoma in the Netherlands: a nationwide study. Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757 [TBL] [Abstract][Full Text] [Related]